Viewing Study NCT06431750


Ignite Creation Date: 2025-12-24 @ 5:01 PM
Ignite Modification Date: 2026-02-23 @ 6:27 AM
Study NCT ID: NCT06431750
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-01-14
First Post: 2024-04-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Juvenile Idiopathic Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Juvenile Idiopathic Arthritis View
None JIA View
None Secukinumab View
None Cosentyx View